Published Online
on October 10, 2005

A more recent version of this article appeared on November 1, 2005

This Article Full Text (PDF) All Versions of this Article: 46/5/1194    most recent 01.HYP.0000187011.44201.2ev1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lohmeier, T. E. Articles by Kieval, R. S. Search for Related Content PubMed PubMed Citation Articles by Lohmeier, T. E. Articles by Kieval, R. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Other hypertension Related Article

Submitted on June 22, 2005
Revised on July 7, 2005

Influence of Prolonged Baroreflex Activation on Arterial Pressure in Angiotensin Hypertension

Thomas E. Lohmeier^*; Terry M. Dwyer; Drew A. Hildebrandt; Eric D. Irwin; Martin A. Rossing; David J. Serdar; and Robert S. Kieval

From the Department of Physiology (T.E.L., T.M.D., D.A.H.) and Surgery (D.A.H.), University of Mississippi Medical Center, Jackson, Miss; Trauma Center (E.D.I.), North Memorial Medical Center, Robbinsdale, Minn; CVRx, Inc (M.A.R., D.J.S., R.S.K.), Maple Grove, Minn.

^* To whom correspondence should be addressed. E-mail: tlohmeier{at}physiology.umsmed.edu.

Abstract--Despite recent evidence indicating sustained activation of the baroreflex during chronic infusion of angiotensin II (Ang II), sinoaortic denervation does not exacerbate the severity of the hypertension. Therefore, to determine whether Ang II hypertension is relatively resistant to the blood pressure-lowering effects of the baroreflex, the carotid baroreflex was electrically activated bilaterally for 7 days in 5 dogs both in the presence and absence of a continuous infusion of Ang II (5 ng/kg per minute) producing high physiological plasma levels of the peptide. Under control conditions, basal values for mean arterial pressure (MAP) and plasma norepinephrine concentration (NE) were 93±1 mm Hg and 99±25 pg/mL, respectively. By day 7 of baroreflex activation, MAP and NE were reduced to 72±4 mm Hg (-21±3 mm Hg) and 56±15 pg/mL, respectively, but PRA was unchanged (control=0.41±0.06 ng ANG I/mL per hour). All values returned to basal levels by the end of a 7-day recovery period. After 7 days of Ang II infusion, MAP increased from 93±3 to 129±3 mm Hg, whereas NE fell from 117±15 to 86±23 pg/mL. During the next 7 days of baroreflex activation/Ang II infusion, further reductions in NE were not statistically significant, and on the final day of baroreflex activation, the reduction in MAP was only 5±1 mm Hg, compared with 21±3 mm Hg in the control normotensive state. These findings indicate that long-term baroreflex-mediated reductions in arterial pressure are markedly diminished, but not totally eliminated, in the presence of hypertension produced by chronic infusion of Ang II.

Key words: arterial pressure • baroreflex • norepinephrine • renin-angiotensin system • sodium • sympathetic nervous system

Related Article:

Baroreflexes in Hypertension: A Mystery Revisited

Pontus B. Persson
Hypertension 2005 46: 1095-1096. [Full Text] [PDF]

This article has been cited by other articles:

				M. J. Joyner, N. Charkoudian, and B. G. Wallin A sympathetic view of the sympathetic nervous system and human blood pressure regulation Exp Physiol, June 1, 2008; 93(6): 715 - 724. [Abstract] [Full Text] [PDF]

				H. C. Hercule, J. Tank, R. Plehm, M. Wellner, A. C. da Costa Goncalves, M. Gollasch, A. Diedrich, J. Jordan, F. C. Luft, and V. Gross Cardiovascular Control: Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice Exp Physiol, November 1, 2007; 92(6): 1014 - 1022. [Abstract] [Full Text] [PDF]

				I. H. Zucker, J. F. Hackley, K. G. Cornish, B. A. Hiser, N. R. Anderson, R. Kieval, E. D. Irwin, D. J. Serdar, J. D. Peuler, and M. A. Rossing Chronic Baroreceptor Activation Enhances Survival in Dogs With Pacing-Induced Heart Failure Hypertension, November 1, 2007; 50(5): 904 - 910. [Abstract] [Full Text] [PDF]

				M. G. Mohaupt, J. Schmidli, and F. C. Luft Management of Uncontrollable Hypertension With a Carotid Sinus Stimulation Device Hypertension, November 1, 2007; 50(5): 825 - 828. [Full Text] [PDF]

				T. E. Lohmeier, T. M. Dwyer, E. D. Irwin, M. A. Rossing, and R. S. Kieval Prolonged Activation of the Baroreflex Abolishes Obesity-Induced Hypertension Hypertension, June 1, 2007; 49(6): 1307 - 1314. [Abstract] [Full Text] [PDF]

				T. E. Lohmeier, D. A. Hildebrandt, T. M. Dwyer, A. M. Barrett, E. D. Irwin, M. A. Rossing, and R. S. Kieval Renal Denervation Does Not Abolish Sustained Baroreflex-Mediated Reductions in Arterial Pressure Hypertension, February 1, 2007; 49(2): 373 - 379. [Abstract] [Full Text] [PDF]

				H. C. Salgado, A. R. Barale, J. A. Castania, B. H. Machado, M. W. Chapleau, and R. Fazan Jr. Baroreflex responses to electrical stimulation of aortic depressor nerve in conscious SHR Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H593 - H600. [Abstract] [Full Text] [PDF]

				D. P. Papadopoulos and V. Papademetriou Resistant Hypertension: Diagnosis and Management Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2006; 11(2): 113 - 118. [Abstract] [PDF]

				P. B. Persson Baroreflexes in Hypertension: A Mystery Revisited Hypertension, November 1, 2005; 46(5): 1095 - 1096. [Full Text] [PDF]